Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03014050 · ClinicalTrials.gov registry record · Early Phase 1
Bio Electro Stimulation Therapy for Parkinson's Disease
A Early Phase 1 study, sponsored by Boston University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 21
- Enrollment target
NCT03014050 is a Early Phase 1 study that has completed, run by Boston University. The registered enrollment target is 21 participants.
The verdict
NCT03014050, a Early Phase 1 study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor dysfunction and non-motor symptoms. Here, the investigators propose in a pilot device feasibility trial to examine whether "Bio Electro Stimulation Therapy" (B.E.S.T.) with a small, non-invasive, handheld electronic device designed to apply micro current stimulation to a person's hand can ameliorate some of the symptoms of PD.
Interventions
- DEVICE e-Tapper TT-R1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-09-22 |
| Est. Completion | 2019-06-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03014050
The ClinicalTrials.gov registry entry for NCT03014050 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which e-Tapper TT-R1 is the first listed.
NCT03014050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03014050 about?
NCT03014050 is a clinical study titled "Bio Electro Stimulation Therapy for Parkinson's Disease". Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor dysfunction and non-motor symptoms. Here, the investigators propose in a pilot device feasibility trial to examine whether "Bio Electro Stimulation Therapy" (B.E.S.T.) with a small, non-invasive, handheld electronic devi...
What is the current status of trial NCT03014050?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 21 participants. The study started on 2017-09-22. Estimated completion is 2019-06-01.
What interventions are being tested in trial NCT03014050?
The interventions under investigation include: e-Tapper TT-R1 (DEVICE).
Who is sponsoring clinical trial NCT03014050?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.